Terrence C. Kearney
Director/Board Member at VERTEX PHARMACEUTICALS INCORPORATED
Net worth: 3 M $ as of 2024-02-28
Profile
Terrence C.
Kearney is on the board of Vertex Pharmaceuticals, Inc.
In his past career Mr. Kearney was Treasurer & Vice President at Abbott Laboratories and Chief Operating Officer at Hospira, Inc.
He received an undergraduate degree from the University of Illinois and an MBA from the University of Denver.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-08-09 | 6,536 ( 0.00% ) | 3 M $ | 2024-02-28 |
Terrence C. Kearney active positions
Companies | Position | Start |
---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Director/Board Member | 2011-05-16 |
Former positions of Terrence C. Kearney
Companies | Position | End |
---|---|---|
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Director/Board Member | 2022-05-31 |
ACCELERON PHARMA INC. | Director/Board Member | 2021-11-18 |
AVEXIS INC | Director/Board Member | 2018-05-13 |
INNOVIVA, INC. | Director/Board Member | 2016-04-25 |
HOSPIRA, INC. | Director of Finance/CFO | 2005-12-31 |
Training of Terrence C. Kearney
University of Illinois | Undergraduate Degree |
University of Denver | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ABBOTT LABORATORIES | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
INNOVIVA, INC. | Health Technology |
Private companies | 4 |
---|---|
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Health Technology |